Valeant Pharma

Visual Financials
Company Name: Valeant Pharmaceuticals International Inc
Ticker Symbol: VRX
CIK Number: 0000885590
WWW Address: http://www.valeant.com
CEO: Mr. Joseph C. Papa
No. of Employees: 21,500
Common Issue Type: CS
Business Description:Valeant Pharmaceuticals International Inc is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.

 
Industry Information: DRUGS - Drug Delivery [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 15.99 Up 0.42 - - 15.57 16.06 15.32 20365689
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 5,572.9 348.5 0.00 -6.94 0.00 0.0 0.0 18.65 - 8.31
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close16.00$
PE Ratio - LTM0.0
Market Capitalisation5,572.9mil
Latest Shares Outstanding348.5mil
Earnings pS (EPS)-6.94$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate0.0%
Float327.6mil
Float as % of Shares Outstanding0.9%
Foreign Sales9,354mil
Domestic Sales320mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin73.0%
EBITDA Margin23.4%
Pre-Tax Profit Margin0.0%
Assets Turnover20.9%
Return on Assets (ROA)-5.2%
Return on Equity (ROE)-53.2%
Return on Capital Invested (ROCI)-1.7%
Current Ratio1.4
Leverage Ratio (Assets/Equity)13.8
Interest Cover-0.3
Total Debt/Equity (Gearing Ratio)9.47
LT Debt/Total Capital90.0%
Working Capital pS4.21$
Cash pS0.00$
Book-Value pS11.28$
Tangible Book-Value pS-90.46$
Cash Flow pS6.58$
Free Cash Flow pS5.52$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.02
Price/Tangible Book Ratio0.00
Price/Cash Flow1.7
Price/Free Cash Flow2.1
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield6.4
Payout Ratio0.0
5-Y Average Payout Ratio30.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---9.0819,351,32839,006,538
4 Weeks16.0610.9412.1228.52718,236,105382,958,207
13 Weeks16.0610.9414.358.5312,303,567799,731,904
26 Weeks18.2510.9413.3216.9915,093,4881,931,966,496
52 Weeks18.658.3117.84-12.7-3117,190,2764,331,949,700
YTD18.258.31-2.1-1317,484,3693,933,983,090
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
15.0114.9513.6313.9513.460.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.310.40.19
Income0.0
Dividend0.0
Capital Spending0.25NA0.26
R&D20.63NA26.42
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %24.824.844.0
Earnings %0.00.0-100.0
EPS %0.00.0-100.0
EPS $-0.05-0.05-0.87
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio3.37
Current Ratio1.4
Quick Ratio (Acid Test)0.8
Liquidity Ratio (Cash)0.30
Receivables Turnover3.7
Average Collection Period97
Working Capital/Equity46.6
Working Capital pS4.22
Cash-Flow pS6.01
Free Cash-Flow pS5.17
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.18
Financial Leverage Ratio (Assets/Equity)9.5
Debt Ratio68.6
Total Debt/Equity (Gearing Ratio)9.47
LT Debt/Equity9.47
LT Debt/Capital Invested111.4
LT Debt/Total Liabilities100.0
Interest Cover0.0
Interest/Capital Invested4.60
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.09
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA19.09
Enterprise Value (EV)/Free Cash Flow7.00
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.02
Price/Cash Flow Ratio1.7
Price/Free Cash Flow Ratio - LTM2.1
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM737.9
P/E Ratio (52 weeks ago) - LTM104.5
5-Y High P/E Ratio-79.9
5-Y Low P/E Ratio-2.5
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM93.3
PER SHARE FIGURES
LT Debt pS115.89
Current Liabilities pS14.01
Tangible Book Value pS - LTM-90.46
Book Value pS - LTM11.28
Capital Invested pS94.70
Cash pS - LTM0.00
Cash Flow pS - LTM6.58
Free Cash Flow pS - LTM5.52
Earnings pS (EPS)-6.94
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin18.57
Free Cash Flow Margin 5YEAR AVG-2.24
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.-0.1
Equity Productivity3.07
Return on Equity (ROE)-0.5
Return on Equity (ROE) - 5YEAR AVRG.-0.1
Capital Invested Productivity0.29
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.20
Return on Assets (ROA)-0.1
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin73.0
Gross Profit Margin - 5YEAR AVRG.0.7
EBITDA Margin - LTM23.4
EBIT Margin - LTM-6.2
Pre-Tax Profit Margin-0.1
Pre-Tax Profit Margin - 5YEAR AVRG.-0.1
Effective Tax Rate-8.7
Effective Tax Rate - 5YEAR AVRG.-13.9
EFFICIENCY RATIOS
Cash Conversion Cycle25,638,788
Revenue per Employee
Net Income per Employee
Average Collection Period25,638,788
Receivables Turnover3.7
Day's Inventory Turnover Ratio
Inventory Turnover2.3
Inventory/Sales11.0
Accounts Payble/Sales3.35
Assets/Revenue5.00
Net Working Capital Turnover6.59
Fixed Assets Turnover0.25
Total Assets Turnover0.2
Revenue per $ Cash17.85
Revenue per $ Plant7.37
Revenue per $ Common Equity3.07
Revenue per $ Capital Invested0.29
Selling, General & Adm/tive (SG&A) as % of Revenue29.0
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue4.4
R&D Expense as % of Revenue - 5YEAR AVRG.4.4

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.